GSK’s Treximet Could Face Market Headaches

Potential hurdles for Pozen-partnered migraine combo drug include BiDil-like woes and switchover problems.

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet